BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jones SC, Banks RE, Haidar A, Gearing AJ, Hemingway IK, Ibbotson SH, Dixon MF, Axon AT. Adhesion molecules in inflammatory bowel disease. Gut 1995;36:724-30. [PMID: 7541009 DOI: 10.1136/gut.36.5.724] [Cited by in Crossref: 131] [Cited by in F6Publishing: 120] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Folwaczny C, Loeschke K, Schnettler D, Jäger G, Wiebecke B, Hoelscher M, Sauer T, König A, Endres SP, Fricke H. Endothelial cell autoantibodies are a marker of disease susceptibility in inflammatory bowel disease but apparently not linked to persistent measles virus infection. Clin Immunol 2000;95:197-202. [PMID: 10866126 DOI: 10.1006/clim.2000.4867] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
2 Vainer B, Nielsen OH. Chemotactic properties of ICAM-1 and PECAM-1 on neutrophil granulocytes in ulcerative colitis: effects of prednisolone and mesalazine: ICAM-1-STIMULATED CHEMOTAXIS IN ULCERATIVE COLITIS. Alimentary Pharmacology & Therapeutics 2000;14:1023-31. [DOI: 10.1046/j.1365-2036.2000.00797.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ko JK, Lam FY, Cheung AP. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol. 2005;11:5787-5794. [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
4 Berrebi D, Languepin J, Ferkdadji L, Foussat A, De Lagausie P, Paris R, Emilie D, Mougenot JF, Cezard JP, Navarro J, Peuchmaur M. Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2003;37:300-308. [PMID: 12960653 DOI: 10.1097/00005176-200309000-00018] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
5 Sandborn WJ, Yednock TA. Novel approaches to treating inflammatory bowel disease: targeting alpha-4 integrin. Am J Gastroenterol. 2003;98:2372-2382. [PMID: 14638336 DOI: 10.1111/j.1572-0241.2003.08703.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 4.1] [Reference Citation Analysis]
6 van Assche G, Rutgeerts P. Antiadhesion molecule therapy in inflammatory bowel disease. Inflamm Bowel Dis. 2002;8:291-300. [PMID: 12131614 DOI: 10.1097/00054725-200207000-00009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 3.4] [Reference Citation Analysis]
7 Smyth CM, Akasheh N, Woods S, Kay E, Morgan RK, Thornton MA, O'Grady A, Cummins R, Sheils O, Smyth P, Gleich GJ, Murray FM, Costello RW. Activated eosinophils in association with enteric nerves in inflammatory bowel disease. PLoS One 2013;8:e64216. [PMID: 23717571 DOI: 10.1371/journal.pone.0064216] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
8 Göke M, Hoffmann JC, Evers J, Krüger H, Manns MP. Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease. J Gastroenterol 1997;32:480-6. [DOI: 10.1007/bf02934086] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
9 Turhan A, Konerding MA, Tsuda A, Ravnic DJ, Hanidziar D, Lin M, Mentzer SJ. Bridging mucosal vessels associated with rhythmically oscillating blood flow in murine colitis. Anat Rec (Hoboken). 2008;291:74-82. [PMID: 18085623 DOI: 10.1002/ar.20628] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
10 Souza HS, Elia CC, Spencer J, MacDonald TT. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut. 1999;45:856-863. [PMID: 10562584 DOI: 10.1136/gut.45.6.856] [Cited by in Crossref: 151] [Cited by in F6Publishing: 145] [Article Influence: 7.2] [Reference Citation Analysis]
11 Kurmaeva E, Boktor M, Zhang S, Bao R, Berney S, Ostanin DV. Roles of T cell-associated L-selectin and β7 integrins during induction and regulation of chronic colitis. Inflamm Bowel Dis 2013;19:2547-59. [PMID: 24132160 DOI: 10.1097/MIB.0b013e3182a8df0a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
12 Laroui H, Viennois E, Xiao B, Canup BS, Geem D, Denning TL, Merlin D. Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis. J Control Release 2014;186:41-53. [PMID: 24810114 DOI: 10.1016/j.jconrel.2014.04.046] [Cited by in Crossref: 85] [Cited by in F6Publishing: 74] [Article Influence: 12.1] [Reference Citation Analysis]
13 Laroux FS, Grisham MB. Immunological basis of inflammatory bowel disease: role of the microcirculation. Microcirculation. 2001;8:283-301. [PMID: 11687942 DOI: 10.1111/j.1549-8719.2001.tb00177.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
14 Yarur AJ, Jain A, Quintero MA, Czul F, Deshpande AR, Kerman DH, Abreu MT. Inflammatory Cytokine Profile in Crohn's Disease Nonresponders to Optimal Antitumor Necrosis Factor Therapy. J Clin Gastroenterol 2019;53:210-5. [PMID: 29517712 DOI: 10.1097/MCG.0000000000001002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Hamzaoui A, Hamzaoui K, Kahan A, Chabbou A. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin in patients with tuberculous pleuritis. Mediators Inflamm 1996;5:276-9. [PMID: 18475740 DOI: 10.1155/S0962935196000403] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
16 Korzenik JR. IBD: A vascular disorder? the case for heparin therapy. Inflamm Bowel Dis 1997;3:87-94. [DOI: 10.1002/ibd.3780030205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
17 Törkvist L, Thorlacius H, Sjöqvist U, Bohman L, Lapidus A, Flood L, Agren B, Raud J, Löfberg R. Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther. 1999;13:1323-1328. [PMID: 10540047 DOI: 10.1046/j.1365-2036.1999.00599.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 3.5] [Reference Citation Analysis]
18 Leone M, Garcin F, Chaabane W, Boutière-albanèse B, Albanèse J, Dignat-georges F, Martin C. Activation des molécules d’adhésion chez les patients en choc septique. Annales Françaises d'Anesthésie et de Réanimation 2003;22:721-9. [DOI: 10.1016/s0750-7658(03)00327-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Yarur AJ, Jain A, Hauenstein SI, Quintero MA, Barkin JS, Deshpande AR, Sussman DA, Singh S, Abreu MT. Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2016;22:409-415. [PMID: 26752470 DOI: 10.1097/mib.0000000000000689] [Cited by in Crossref: 74] [Cited by in F6Publishing: 33] [Article Influence: 14.8] [Reference Citation Analysis]
20 Pepe M, Carulli E, Forleo C, Moscarelli M, Di Cillo O, Bortone AS, Nestola PL, Biondi-Zoccai G, Giordano A, Favale S. Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk. Inflamm Bowel Dis 2021;27:725-31. [PMID: 32592478 DOI: 10.1093/ibd/izaa160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Reed KL, Fruin AB, Gower AC, Gonzales KD, Stucchi AF, Andry CD, O’Brien M, Becker JM. NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci. 2005;50:2366-2378. [PMID: 16416193 DOI: 10.1007/s10620-005-3066-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
22 Kawachi S, Jennings S, Panes J, Cockrell A, Laroux FS, Gray L, Perry M, van der Heyde H, Balish E, Granger DN, Specian RA, Grisham MB. Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2000;278:G734-43. [DOI: 10.1152/ajpgi.2000.278.5.g734] [Cited by in Crossref: 58] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
23 Vainer B, Sørensen S, Seidelin J, Nielsen OH, Horn T. Expression of ICAM-1 in colon epithelial cells: an ultrastructural study performed on in vivo and in vitro models. Virchows Arch. 2003;443:774-781. [PMID: 14564519 DOI: 10.1007/s00428-003-0900-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
24 Cho EJ, Shin JS, Chung KS, Lee YS, Cho YW, Baek NI, Chung HG, Lee KT. Arvelexin inhibits colonic inflammation by suppression of NF-κB activation in dextran sulfate sodium-induced mice and TNF-α-induced colonic epithelial cells. J Agric Food Chem 2012;60:7398-407. [PMID: 22794033 DOI: 10.1021/jf3009553] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
25 Krejsek J, Slezák R, Kopecky O, Derner V, Andrys C. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome. Clin Rheumatol 1997;16:149-53. [DOI: 10.1007/bf02247843] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Chen Y, Zhang HS, Fong GH, Xi QL, Wu GH, Bai CG, Ling ZQ, Fan L, Xu YM, Qin YQ. PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function. J Biol Chem. 2015;290:20580-20589. [PMID: 26124271 DOI: 10.1074/jbc.m115.653584] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
27 Gu P, Theiss A, Han J, Feagins LA. Increased Cell Adhesion Molecules, PECAM-1, ICAM-3, or VCAM-1, Predict Increased Risk for Flare in Patients With Quiescent Inflammatory Bowel Disease. J Clin Gastroenterol 2017;51:522-7. [PMID: 27552332 DOI: 10.1097/MCG.0000000000000618] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
28 Cheng Y, Wei Y, Yang W, Cai Y, Chen B, Yang G, Shang H, Zhao W. Ghrelin Attenuates Intestinal Barrier Dysfunction Following Intracerebral Hemorrhage in Mice. Int J Mol Sci 2016;17:E2032. [PMID: 27929421 DOI: 10.3390/ijms17122032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
29 Yarur AJ, Quintero MA, Jain A, Czul F, Barkin JS, Abreu MT. Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease. Inflamm Bowel Dis. 2017;23:158-164. [PMID: 27930409 DOI: 10.1097/mib.0000000000000991] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 7.7] [Reference Citation Analysis]
30 Plevy S, Silverberg MS, Lockton S, Stockfisch T, Croner L, Stachelski J, Brown M, Triggs C, Chuang E, Princen F. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients. Inflamm Bowel Dis. 2013;19:1139-1148. [PMID: 23518807 DOI: 10.1097/mib.0b013e318280b19e] [Cited by in Crossref: 71] [Cited by in F6Publishing: 35] [Article Influence: 8.9] [Reference Citation Analysis]
31 Watanabe C, Miura S, Hokari R, Teramoto K, Ogino T, Komoto S, Hara Y, Koseki S, Tsuzuki Y, Nagata H. Spatial heterogeneity of TNF-alpha-induced T cell migration to colonic mucosa is mediated by MAdCAM-1 and VCAM-1. Am J Physiol Gastrointest Liver Physiol. 2002;283:G1379-G1387. [PMID: 12388196 DOI: 10.1152/ajpgi.00026.2002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
32 Jurisic G, Sundberg JP, Bleich A, Leiter EH, Broman KW, Buechler G, Alley L, Vestweber D, Detmar M. Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease. Genes Immun 2010;11:219-31. [PMID: 20220769 DOI: 10.1038/gene.2010.4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
33 Teramoto K, Miura S, Tsuzuki Y, Hokari R, Watanabe C, Inamura T, Ogawa T, Hosoe N, Nagata H, Ishii H, Hibi T. Increased lymphocyte trafficking to colonic microvessels is dependent on MAdCAM-1 and C-C chemokine mLARC/CCL20 in DSS-induced mice colitis. Clin Exp Immunol 2005;139:421-8. [PMID: 15730387 DOI: 10.1111/j.1365-2249.2004.02716.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
34 Bowen-Yacyshyn MB, Bennett CF, Nation N, Rayner D, Yacyshyn BR. Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2 microglobulin transgenic rat model. J Pharmacol Exp Ther 2002;302:908-17. [PMID: 12183646 DOI: 10.1124/jpet.102.036053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
35 Peyrin-biroulet L, Rodriguez-guéant R, Chamaillard M, Desreumaux P, Xia B, Bronowicki J, Bigard M, Guéant J. Vascular and Cellular Stress in Inflammatory Bowel Disease: Revisiting the Role of Homocysteine. Am J Gastroenterology 2007;102:1108-15. [DOI: 10.1111/j.1572-0241.2007.01170.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
36 Holmer AK, Battat R, Dulai PS, Vande Casteele N, Nguyen N, Jain A, Miralles A, Neill J, Le H, Singh S, Rivera-Nieves J, Sandborn WJ, Boland BS. Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease. Therap Adv Gastroenterol 2020;13:1756284820971214. [PMID: 33240396 DOI: 10.1177/1756284820971214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Yacyshyn B, Chey WY, Wedel MK, Yu RZ, Paul D, Chuang E. A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with active Crohn's disease. Clin Gastroenterol Hepatol 2007;5:215-20. [PMID: 17296530 DOI: 10.1016/j.cgh.2006.11.001] [Cited by in Crossref: 93] [Cited by in F6Publishing: 80] [Article Influence: 6.6] [Reference Citation Analysis]
38 Higuchi K, Arakawa T, Uchida T, Nakagawa K, Nakamura S, Matsumoto T, Fukuda T, Kobayashi K, Kuroki T. In Situ Expression of Cell Adhesion Molecules in Chronic Gastritis with Helicobacter pylori Infection: . Journal of Clinical Gastroenterology 1997;25:S215-21. [DOI: 10.1097/00004836-199700001-00034] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
39 Kruschewski M, Anderson T, Loddenkemper C, Buhr HJ. Endothelin-1 Receptor Antagonist (LU-135252) Improves the Microcirculation and Course of TNBS Colitis in Rats. Dig Dis Sci 2006;51:1461-70. [DOI: 10.1007/s10620-005-9019-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
40 Vítek L, Schwertner HA. The Heme Catabolic Pathway and its Protective Effects on Oxidative Stress‐Mediated Diseases. Elsevier; 2007. pp. 1-57. [DOI: 10.1016/s0065-2423(06)43001-8] [Cited by in Crossref: 128] [Cited by in F6Publishing: 48] [Article Influence: 9.1] [Reference Citation Analysis]
41 Okanishi H, Kabeya H, Maruyama S, Kagawa Y, Watari T. Activation of nuclear factor-kappa B and cell adhesion molecule mRNA expression in duodenal mucosa of dogs with lymphocytic-plasmacytic enteritis. Veterinary Immunology and Immunopathology 2013;154:145-52. [DOI: 10.1016/j.vetimm.2013.05.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
42 Schäppi MG, Klein NJ, Lindley KJ, Rampling D, Smith VV, Goldblatt D, Milla PJ. The Nature of Colitis in Chronic Granulomatous Disease: . Journal of Pediatric Gastroenterology and Nutrition 2003;36:623-31. [DOI: 10.1097/00005176-200305000-00006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
43 Vogel ME, Idelman G, Konaniah ES, Zucker SD. Bilirubin Prevents Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor-Deficient Mice by Inhibiting Endothelial VCAM-1 and ICAM-1 Signaling. J Am Heart Assoc 2017;6:e004820. [PMID: 28365565 DOI: 10.1161/JAHA.116.004820] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
44 Matsuzaki K, Tsuzuki Y, Matsunaga H, Inoue T, Miyazaki J, Hokari R, Okada Y, Kawaguchi A, Nagao S, Itoh K. In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. Clin Exp Immunol. 2005;140:22-31. [PMID: 15762871 DOI: 10.1111/j.1365-2249.2005.02742.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
45 Cook-Mills JM, Marchese ME, Abdala-Valencia H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal 2011;15:1607-38. [PMID: 21050132 DOI: 10.1089/ars.2010.3522] [Cited by in Crossref: 241] [Cited by in F6Publishing: 214] [Article Influence: 24.1] [Reference Citation Analysis]
46 Thayse K, Kindt N, Laurent S, Carlier S. VCAM-1 Target in Non-Invasive Imaging for the Detection of Atherosclerotic Plaques. Biology (Basel) 2020;9:E368. [PMID: 33138124 DOI: 10.3390/biology9110368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Hyams JS, Wilson DC, Thomas A, Heuschkel R, Mitton S, Mitchell B, Daniels R, Libonati MA, Zanker S, Kugathasan S. Natalizumab Therapy for Moderate to Severe Crohn Disease in Adolescents. Journal of Pediatric Gastroenterology & Nutrition 2007;44:185-91. [DOI: 10.1097/01.mpg.0000252191.05170.e7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
48 Day R, Ilyas M, Daszak P, Talbot I, Forbes A. Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy. Dig Dis Sci. 1999;44:2508-2515. [PMID: 10630505 DOI: 10.1023/a:1026647308089] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
49 Derici U, Tuncer C, Ebinç FA, Mutluay R, Yakaryilmaz F, Kulaksizoglu S, Soylemezoglu O, Sindel S. Does the urinary excretion of alpha1-microglobulin and albumin predict clinical disease activity in ulcerative colitis? Adv Ther. 2008;25:1342-1352. [PMID: 19002407 DOI: 10.1007/s12325-008-0109-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
50 Catalan-Serra I, Brenna Ø. Immunotherapy in inflammatory bowel disease: Novel and emerging treatments. Hum Vaccin Immunother 2018;14:2597-611. [PMID: 29624476 DOI: 10.1080/21645515.2018.1461297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
51 Rubin DT, Naik S, Kondragunta V, Rao T, Jain A. Detection of adalimumab and antibodies to adalimumab using a homogeneous mobility shift assay. Curr Med Res Opin 2017;33:837-43. [PMID: 28145781 DOI: 10.1080/03007995.2017.1289908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
52 Liu ZX, Hiwatashi N, Noguchi M, Toyota T. Increased expression of costimulatory molecules on peripheral blood monocytes in patients with Crohn's disease. Scand J Gastroenterol. 1997;32:1241-1246. [PMID: 9438323 DOI: 10.3109/00365529709028154] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
53 Gulubova MV, Manolova IM, Vlaykova TI, Prodanova M, Jovchev JP. Adhesion molecules in chronic ulcerative colitis. Int J Colorectal Dis. 2007;22:581-589. [PMID: 17109102 DOI: 10.1007/s00384-006-0236-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
54 Vitale G, Mansueto S, Gambino G, Mocciaro C, La Russa C, Mansueto P, Zambito MA, Ferlazzo V, Barbera C, La Rosa M, Milano S, Cillari E. Differential up-regulation of circulating soluble selectins and endothelial adhesion molecules in Sicilian patients with Boutonneuse fever. Clin Exp Immunol 1999;117:304-8. [PMID: 10444262 DOI: 10.1046/j.1365-2249.1999.00956.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
55 Mcgowan I, Chalmers A, Smith G, Jewell D. ADVANCES IN MUCOSAL IMMUNOLOGY. Gastroenterology Clinics of North America 1997;26:145-73. [DOI: 10.1016/s0889-8553(05)70291-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Korzenik JR. IBD: A Vascular Disorder? The Case for Heparin Therapy: . Inflammatory Bowel Diseases 1997;3:87-94. [DOI: 10.1097/00054725-199706000-00004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
57 Greuter T, Rogler G. Alicaforsen in the treatment of pouchitis. Immunotherapy 2017;9:1143-52. [PMID: 29067882 DOI: 10.2217/imt-2017-0085] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
58 Bendjelloul F, Rossmann P, Malý P, Mandys V, Jirkovská M, Prokesová L, Tucková L, Tlaskalová-Hogenová H. Detection of ICAM-1 in experimentally induced colitis of ICAM-1-deficient and wild-type mice: an immunohistochemical study. Histochem J 2000;32:703-9. [PMID: 11254085 DOI: 10.1023/a:1004191825644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
59 van Dieren JM, Kuipers EJ, Samsom JN, Nieuwenhuis EE, van der Woude JC. Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: Their mechanisms of action and role in the treatment of IBD: . Inflammatory Bowel Diseases 2006;12:311-27. [DOI: 10.1097/01.mib.0000209787.19952.53] [Cited by in Crossref: 43] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
60 Van Deventer SJH, Wedel MK, Baker BF, Xia S, Chuang E, Miner PB. A Phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis. Aliment Pharmacol Ther 2006;23:1415-25. [DOI: 10.1111/j.1365-2036.2006.02910.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 71] [Article Influence: 6.1] [Reference Citation Analysis]
61 Thapa D, Lee JS, Park M, Cho M, Park Y, Choi HG, Jeong TC, Kim J. Inhibitory effects of clotrimazole on TNF-α-induced adhesion molecule expression and angiogenesis. Arch Pharm Res 2009;32:593-603. [DOI: 10.1007/s12272-009-1416-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
62 Kawachi S, Morise Z, Jennings SR, Conner E, Cockrell A, Laroux SF, Chervenak RP, Wolcott M, van der Heyde H, Gray L, Feng L, Granger ND, Specian RA, Grisham MB. Cytokine and Adhesion Molecule Expression in SCID Mice Reconstituted with CD4+ T Cells: . Inflammatory Bowel Diseases 2000;6:171-80. [DOI: 10.1097/00054725-200008000-00003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
63 Cibor D, Domagala-Rodacka R, Rodacki T, Jurczyszyn A, Mach T, Owczarek D. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World J Gastroenterol. 2016;22:1067-1077. [PMID: 26811647 DOI: 10.3748/wjg.v22.i3.1067] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 9.5] [Reference Citation Analysis]
64 Isakov O, Dotan I, Ben-Shachar S. Machine Learning-Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017;23:1516-1523. [PMID: 28795970 DOI: 10.1097/mib.0000000000001222] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
65 Veres G, Helin T, Arato A, Färkkilä M, Kantele A, Suomalainen H, Savilahti E. Increased expression of intercellular adhesion molecule-1 and mucosal adhesion molecule alpha4beta7 integrin in small intestinal mucosa of adult patients with food allergy. Clin Immunol 2001;99:353-9. [PMID: 11358431 DOI: 10.1006/clim.2001.5032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
66 Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol. 2000;95:359-367. [PMID: 10685736 DOI: 10.1111/j.1572-0241.2000.t01-1-01790.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 46] [Article Influence: 0.7] [Reference Citation Analysis]
67 Fonsatti E, Altomonte M, Coral S, Cattarossi I, Nicotra MR, Gasparollo A, Natali PG, Maio M. Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells. Br J Cancer 1997;76:1255-61. [PMID: 9374368 DOI: 10.1038/bjc.1997.545] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
68 Huang J, Wan D, Li J, Chen H, Huang K, Zheng L. Histone acetyltransferase PCAF regulates inflammatory molecules in the development of renal injury. Epigenetics 2015;10:62-72. [PMID: 25496441 DOI: 10.4161/15592294.2014.990780] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 8.5] [Reference Citation Analysis]
69 Chen K, Long YM, Wang H, Lan L, Lin ZH. Activation of nuclear factor-kappa B and effects of pyrrolidine dithiocarbamate on TNBS-induced rat colitis. World J Gastroenterol 2005;11:1508-14. [PMID: 15770728 DOI: 10.3748/wjg.v11.i10.1508] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
70 Bevivino G, Sedda S, Marafini I, Monteleone G. Oligonucleotide-Based Therapies for Inflammatory Bowel Disease. BioDrugs 2018;32:331-8. [PMID: 29948918 DOI: 10.1007/s40259-018-0286-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
71 Sans M, Fuster D, Vázquez A, Setoain FJ, Piera C, Piqué JM, Panés J. 123Iodine-labelled anti-VCAM-1 antibody scintigraphy in the assessment of experimental colitis. Eur J Gastroenterol Hepatol 2001;13:31-8. [PMID: 11204806 DOI: 10.1097/00042737-200101000-00006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
72 Budak E, Madazli R, Aksu MF, Benian A, Gezer A, Palit N, Yildizfer F. Vascular cell adhesion molecule-1 (VCAM-1) and leukocyte activation in pre-eclampsia and eclampsia. Int J Gynaecol Obstet 1998;63:115-21. [PMID: 9856316 DOI: 10.1016/s0020-7292(98)00138-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
73 Murthy S, Flanigan A, Osborne BJ, Murthy NS. Inflammatory bowel diseases: a new wave of therapy. Expert Opinion on Therapeutic Patents 2005;8:785-818. [DOI: 10.1517/13543776.8.7.785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
74 Turina MC, Landewé R, Baeten D. Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpA. Expert Review of Clinical Immunology 2017;13:333-44. [DOI: 10.1080/1744666x.2017.1244004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
75 Lazaris AC, Dicoglou C, Tseleni-balafouta S, Paraskevakou H, Davaris PS. In situ expression of E-selectin and intercellular adhesion molecule-1 in chronic inflammatory diseases of the gastrointestinal tract. APMIS 1999;107:819-27. [DOI: 10.1111/j.1699-0463.1999.tb01477.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
76 Sans M, Panés J, Ardite E, Elizalde JI, Arce Y, Elena M, Palacín A, Fernández-Checa JC, Anderson DC, Lobb R. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology. 1999;116:874-883. [PMID: 10092309 DOI: 10.1016/s0016-5085(99)70070-3] [Cited by in Crossref: 133] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
77 Ghaisas NK, Foley J, O’briain D, Crean P, Kelleher D, Walsh M. Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement. Journal of the American College of Cardiology 2000;36:2257-62. [DOI: 10.1016/s0735-1097(00)00998-0] [Cited by in Crossref: 84] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
78 Granger DN, Grisham MB, Kevil CG. Recruitment of Inflammatory and Immune Cells in the Gut: Physiology and Pathophysiology. Physiology of the Gastrointestinal Tract. Elsevier; 2006. pp. 1137-62. [DOI: 10.1016/b978-012088394-3/50049-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
79 Bendjelloul F, Malý P, Mandys V, Jirkovská M, Prokesová L, Tucková L, Tlaskalová-Hogenová H. Intercellular adhesion molecule-1 (ICAM-1) deficiency protects mice against severe forms of experimentally induced colitis. Clin Exp Immunol 2000;119:57-63. [PMID: 10606964 DOI: 10.1046/j.1365-2249.2000.01090.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
80 Theodoratou E, Campbell H, Ventham NT, Kolarich D, Pučić-Baković M, Zoldoš V, Fernandes D, Pemberton IK, Rudan I, Kennedy NA, Wuhrer M, Nimmo E, Annese V, McGovern DP, Satsangi J, Lauc G. The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol 2014;11:588-600. [PMID: 24912389 DOI: 10.1038/nrgastro.2014.78] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 11.7] [Reference Citation Analysis]
81 Zhang HF, Wang YL, Gao C, Gu YT, Huang J, Wang JH, Wang JH, Zhang Z. Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-κB and p38 MAPK signaling pathways in 5/6 nephrectomized rats. Acta Pharmacol Sin 2018;39:1855-64. [PMID: 29795135 DOI: 10.1038/s41401-018-0026-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
82 Hong J, Leung E, Fraser AG, Merriman TR, Vishnu P, Krissansen GW. Polymorphisms in NFKBIA and ICAM-1 genes in New Zealand Caucasian Crohn's disease patients. J Gastroenterol Hepatol. 2007;22:1666-1670. [PMID: 17593226 DOI: 10.1111/j.1440-1746.2007.05020.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
83 Yonekawa K, Harlan JM. Targeting leukocyte integrins in human diseases. J Leukoc Biol 2005;77:129-40. [PMID: 15548573 DOI: 10.1189/jlb.0804460] [Cited by in Crossref: 112] [Cited by in F6Publishing: 100] [Article Influence: 6.6] [Reference Citation Analysis]
84 Battat R, Dulai PS, Vande Casteele N, Evans E, Hester KD, Webster E, Jain A, Proudfoot JA, Mairalles A, Neill J, Singh S, Chang JT, Rivera-Nieves J, Sandborn WJ, Boland BS. Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis. Inflamm Bowel Dis 2019;25:410-20. [PMID: 30295781 DOI: 10.1093/ibd/izy307] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
85 Thomas PD, Forbes A, Price AB, Nicholls RJ, Ciclitira PJ. Differential expression of cell adhesion molecules within inflamed ileal pouch mucosa: relationship to recruited cell subtypes. Eur J Gastroenterol Hepatol. 2002;14:137-144. [PMID: 11981337 DOI: 10.1097/00042737-200202000-00007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
86 Rutgeerts P, Van Deventer S, Schreiber S. The expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition: REVIEW: BIOLOGICAL STRATEGIES IN INFLAMMATORY BOWEL DISEASE. Alimentary Pharmacology & Therapeutics 2003;17:1435-50. [DOI: 10.1046/j.1365-2036.2003.01603.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
87 Baker OJ, Camden JM, Rome DE, Seye CI, Weisman GA. P2Y2 nucleotide receptor activation up-regulates vascular cell adhesion molecule-1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line. Mol Immunol 2008;45:65-75. [PMID: 17599409 DOI: 10.1016/j.molimm.2007.05.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
88 Van Rees EP, Palmen MJ, Van De Goot FR, Macher BA, Dieleman LA. Leukocyte migration in experimental inflammatory bowel disease. Mediators Inflamm 1997;6:85-93. [PMID: 18472841 DOI: 10.1080/09629359791776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
89 Velikova G, Banks RE, Gearing A, Hemingway I, Forbes MA, Preston SR, Hall NR, Jones M, Wyatt J, Miller K. Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer. 1998;77:1857-1863. [PMID: 9667659 DOI: 10.1038/bjc.1998.309] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 2.3] [Reference Citation Analysis]
90 Leone M, Boutière B, Camoin-Jau L, Albanèse J, Horschowsky N, Mège JL, Martin C, Dignat-George F. Systemic endothelial activation is greater in septic than in traumatic-hemorrhagic shock but does not correlate with endothelial activation in skin biopsies. Crit Care Med 2002;30:808-14. [PMID: 11940750 DOI: 10.1097/00003246-200204000-00015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
91 Caprilli R, Viscido A, Guagnozzi D. Review article: biological agents in the treatment of Crohn's disease. Aliment Pharmacol Ther 2002;16:1579-90. [PMID: 12197837 DOI: 10.1046/j.1365-2036.2002.01319.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
92 Philpott JR, Miner PB Jr. Antisense inhibition of ICAM-1 expression as therapy provides insight into basic inflammatory pathways through early experiences in IBD. Expert Opin Biol Ther. 2008;8:1627-1632. [PMID: 18774928 DOI: 10.1517/14712598.8.10.1627] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
93 Meenan J, Spaans J, Grool TA, Pals ST, Tytgat GN, van Deventer SJ. Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. Gut. 1997;40:241-246. [PMID: 9071939 DOI: 10.1136/gut.40.2.241] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 2.8] [Reference Citation Analysis]
94 Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr HA, Hartmann G, Dinarello CA, Endres S, Eigler A. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol 2001;281:R1264-73. [PMID: 11557635 DOI: 10.1152/ajpregu.2001.281.4.R1264] [Cited by in Crossref: 182] [Cited by in F6Publishing: 105] [Article Influence: 9.1] [Reference Citation Analysis]
95 Kruschewski M, Anderson T, Buhr HJ, Loddenkemper C. Selective COX-2 Inhibition Reduces Leukocyte Sticking and Improves the Microcirculation in TNBS Colitis. Dig Dis Sci 2006;51:662-70. [DOI: 10.1007/s10620-006-3189-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
96 Martinesi M, Ambrosini S, Treves C, Zuegel U, Steinmeyer A, Vito A, Milla M, Bonanomi AG, Stio M. Role of vitamin D derivatives in intestinal tissue of patients with inflammatory bowel diseases. J Crohns Colitis 2014;8:1062-71. [PMID: 24630484 DOI: 10.1016/j.crohns.2014.02.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
97 Barrier BF, Sharpe-timms KL. Expression of Soluble Adhesion Molecules in Sera of Women With Stage III and IV Endometriosis. Journal of the Society for Gynecologic Investigation 2016;9:98-101. [DOI: 10.1177/107155760200900209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
98 Vainer B, Nielsen OH, Horn T. Comparative Studies of the Colonic In Situ Expression of Intercellular Adhesion Molecules (ICAM-1, -2, and -3), β2 Integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in Ulcerative Colitis and Crohn's Disease: . The American Journal of Surgical Pathology 2000;24:1115-24. [DOI: 10.1097/00000478-200008000-00009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 2.1] [Reference Citation Analysis]
99 Miki C, Ohmori Y, Yoshiyama S, Toiyama Y, Araki T, Uchida K, Kusunoki M. Factors predicting postoperative infectious complications and early induction of inflammatory mediators in ulcerative colitis patients. World J Surg 2007;31:522-9; discussion 530-1. [PMID: 17334865 DOI: 10.1007/s00268-006-0131-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
100 Hopkin SJ, Lewis JW, Krautter F, Chimen M, McGettrick HM. Triggering the Resolution of Immune Mediated Inflammatory Diseases: Can Targeting Leukocyte Migration Be the Answer? Front Pharmacol 2019;10:184. [PMID: 30881306 DOI: 10.3389/fphar.2019.00184] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
101 Sales-Campos H, de Souza PR, Basso PJ, Nardini V, Silva A, Banquieri F, Alves VB, Chica JE, Nomizo A, Cardoso CR. Amelioration of experimental colitis after short-term therapy with glucocorticoid and its relationship to the induction of different regulatory markers. Immunology 2017;150:115-26. [PMID: 27618667 DOI: 10.1111/imm.12672] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
102 Schreiber S, Nikolaus S, Malchow H, Kruis W, Lochs H, Raedler A, Hahn EG, Krummenerl T, Steinmann G. Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease. Gastroenterology. 2001;120:1339-1346. [PMID: 11313303 DOI: 10.1053/gast.2001.24015] [Cited by in Crossref: 138] [Cited by in F6Publishing: 113] [Article Influence: 6.9] [Reference Citation Analysis]
103 Imafuku K, Kamaguchi M, Natsuga K, Nakamura H, Shimizu H, Iwata H. Zonula occludens-1 demonstrates a unique appearance in buccal mucosa over several layers. Cell Tissue Res 2021;384:691-702. [PMID: 33635425 DOI: 10.1007/s00441-021-03425-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Farkas S, Herfarth H, Rössle M, Schroeder J, Steinbauer M, Guba M, Beham A, Schölmerich J, Jauch KW, Anthuber M. Quantification of mucosal leucocyte endothelial cell interaction by in vivo fluorescence microscopy in experimental colitis in mice. Clin Exp Immunol 2001;126:250-8. [PMID: 11703368 DOI: 10.1046/j.1365-2249.2001.01544.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
105 Zezos P, Kouklakis G, Saibil F. Inflammatory bowel disease and thromboembolism. World J Gastroenterol. 2014;20:13863-13878. [PMID: 25320522 DOI: 10.3748/wjg.v20.i38.13863] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 46] [Article Influence: 12.2] [Reference Citation Analysis]
106 Vainer B. Role of Cell Adhesion Molecules in Inflammatory Bowel Diseases. Scandinavian Journal of Gastroenterology 2009;32:401-10. [DOI: 10.3109/00365529709025072] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
107 Bui TM, Wiesolek HL, Sumagin R. ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol 2020;108:787-99. [PMID: 32182390 DOI: 10.1002/JLB.2MR0220-549R] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 20.0] [Reference Citation Analysis]
108 Neuman MG. Osteopontin biomarker in inflammatory bowel disease, animal models and target for drug discovery. Dig Dis Sci 2012;57:1430-1. [PMID: 22410852 DOI: 10.1007/s10620-012-2120-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
109 Bhatti M, Chapman P, Peters M, Haskard D, Hodgson HJ. Visualising E-selectin in the detection and evaluation of inflammatory bowel disease. Gut 1998;43:40-7. [PMID: 9771404 DOI: 10.1136/gut.43.1.40] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 2.5] [Reference Citation Analysis]
110 Sleutjes JAM, van Lennep JER, van der Woude CJ, de Vries AC. Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management. Therap Adv Gastroenterol 2021;14:17562848211032126. [PMID: 34377149 DOI: 10.1177/17562848211032126] [Reference Citation Analysis]
111 Rijcken E, Krieglstein CF, Anthoni C, Laukoetter MG, Mennigen R, Spiegel HU, Senninger N, Bennett CF, Schuermann G. ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease. Gut 2002;51:529-35. [PMID: 12235075 DOI: 10.1136/gut.51.4.529] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
112 Bai A, Peng Z. Biological therapies of inflammatory bowel disease. Immunotherapy. 2010;2:727-742. [PMID: 20874655 DOI: 10.2217/imt.10.51] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
113 Brookes MJ, Green JRB. Maintenance of Remission in Crohn???s Disease: Current and Emerging Therapeutic Options. Drugs 2004;64:1069-89. [DOI: 10.2165/00003495-200464100-00004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
114 Sans M, Salas A, Soriano A, Prats N, Gironella M, Pizcueta P, Elena M, Anderson DC, Piqué JM, Panés J. Differential role of selectins in experimental colitis. Gastroenterology. 2001;120:1162-1172. [PMID: 11266380 DOI: 10.1053/gast.2001.23252] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
115 Keshavan P, Deem TL, Schwemberger SJ, Babcock GF, Cook-Mills JM, Zucker SD. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol. 2005;174:3709-3718. [PMID: 15749910 DOI: 10.4049/jimmunol.174.6.3709] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 6.6] [Reference Citation Analysis]
116 Koutroubakis IE, Petinaki E, Vardas E, Dimoulios P, Roussomoustakaki M, Maniatis AN, Kouroumalis EA. Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel disease: . European Journal of Gastroenterology & Hepatology 2002;14:405-8. [DOI: 10.1097/00042737-200204000-00012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
117 Vainer B, Nielsen OH, Horn T. Expression of E-selectin, sialyl Lewis X, and macrophage inflammatory protein-1alpha by colonic epithelial cells in ulcerative colitis. Dig Dis Sci 1998;43:596-608. [PMID: 9539657 DOI: 10.1023/a:1018875410987] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
118 Scarozza P, Schmitt H, Monteleone G, Neurath MF, Atreya R. Oligonucleotides-A Novel Promising Therapeutic Option for IBD. Front Pharmacol 2019;10:314. [PMID: 31068803 DOI: 10.3389/fphar.2019.00314] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
119 Goggins MG, Goh J, O’Connell MA, Weir DG, Kelleher D, Mahmud N. Soluble adhesion molecules in inflammatory bowel disease. Ir J Med Sci. 2001;170:107-111. [PMID: 11491044 DOI: 10.1007/bf03168821] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
120 Vainer B. Intercellular adhesion molecule-1 (ICAM-1) in ulcerative colitis: presence, visualization, and significance. APMIS Suppl 2010;:1-43. [PMID: 20653648 DOI: 10.1111/j.1600-0463.2010.02647.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]